Fresh analysis indicates that people who discontinue new slimming jabs like Mounjaro or Wegovy can put back on lost weight much more quickly than those who stop conventional diet and exercise programs.
Findings released in a leading health publication demonstrates that while obese individuals often shed substantial amounts of their total mass while using the jabs, the mass returns at an estimated rate of 0.8 kg per month after stopping.
"Individuals buying these medications need to be aware of the danger of fast weight regain when the therapy concludes," stated researcher Dr. Susan Jebb.
That rate of regain implies a return to starting mass within about 18 months.
Analyzing Treatments
The study, which reviewed dozens of studies involving thousands of participants, contrasted the results of these new drugs with other pills.
Scientists point out that individuals who lose weight through dieting typically experience a slower creep back—perhaps 0.1 kg a month—once they finish.
Understanding the Rapid Regain
Nutrition scientists suggest the way of the jabs accounts for the accelerated rebound.
GLP-1 drugs copy a body's own chemical called glucagon-like peptide-1, which moderates appetite.
"Artificially providing GLP-1 concentrations far above than the body's typical production could lead to the body to produce less of its endogenous GLP-1, and could reduce responsiveness to its actions," said Dr. Adam Collins, a dietetics researcher.
"Discontinuation of this medication means appetite is uncontrolled, making overeating a significant risk."
A Lifelong Issue?
Medical guidelines recommend the injections for people with obesity-related medical conditions, accompanied by recommended diet and exercise modifications.
A number of clinicians contend that, considering the high risk of weight regain, the treatment should be considered life-long.
This perspective is supported by pharmaceutical companies, who say that the results "underscore the persistent character of obesity," similar to managing conditions like diabetes.
User Experiences
People who have come off the jabs report a intense return of cravings.
"It was like something activating and you become ravenous," described an individual.
The struggle is exacerbated if patients have not adopted permanent dietary or behavioural changes during therapy.
Significant Adoption
Figures show that a significant number of adults in the UK have used these injections in the past year, with demand being substantial.
- Use is more common among females than men.
- The 40s and 50s age group shows the greatest level of interest.
- A large proportion access the medications through private prescriptions rather than the NHS.
Ultimately, experts emphasize that while the jabs are powerful agents for weight loss, they are not a permanent solution and lasting health benefits hinges on ongoing lifestyle changes.
